The team found that the U.S. Food and Drug Administration (FDA)-approved drug sevelamer, typically prescribed to help bind excess phosphorus in the blood of people with chronic kidney disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback